Skip to main content
Fig. 3 | Lipids in Health and Disease

Fig. 3

From: Effects of extended-release niacin/laropiprant on correlations between apolipoprotein B, LDL-cholesterol and non-HDL-cholesterol in patients with type 2 diabetes

Fig. 3

Scatterplots of apoB versus non-HDL-C at baseline (a) and following treatment with ERN/LRPT or placebo at Week 12 (b). The upper thresholds for the less-stringent non-HDL-C <130 mg/dL and apoB <90 mg/dL goals are denoted by horizontal and vertical lines, respectively. Right lower quadrant shows the large number of subjects who met non-HDL-C goal <130 mg/dL but did not reach apoB goal <90 mg/dL after niacin treatment

Back to article page

Lipids in Health and Disease

ISSN: 1476-511X